Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine plus amodiaquine for seasonal malaria chemoprevention in school-aged children in Mali
PACTR202007754558749Phase 4Completed
- Sponsor
- Université des Sciences, des Techniques et des Technologies de Bamako
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dihydroartemisinin + piperaquine, sulfadoxine + pyrimethamine, amodiaquine and albendazole in malaria, sponsored by Université des Sciences, des Techniques et des Technologies de Bamako. Started Sep 2020; status: completed.
02
Drugs
dihydroartemisinin + piperaquinesulfadoxine + pyrimethamineamodiaquinealbendazole
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202007754558749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202007754558749.